Multiple Sclerosis and Other Demyelinating Diseases ,
New diagnostic criteria for multiple sclerosis: guidelines for research protocols, Ann. Neurol, vol.13, pp.227-231, 1983. ,
Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria, Lancet Neurol, vol.17, pp.162-173, 2018. ,
Epidemiology of multiple sclerosis, Rev. Neurol, vol.172, pp.3-13, 2016. ,
URL : https://hal.archives-ouvertes.fr/hal-01255824
Geographic variations of multiple sclerosis in France, Brain, vol.133, pp.1889-1899, 2010. ,
, Global, regional, and national burden of multiple sclerosis 1990-2016: a systematic analysis for the Global Burden of Disease Study, Lancet Neurol, vol.18, pp.269-285, 2016.
Environmental factors in multiple sclerosis, Expert Rev. Neurother, vol.13, pp.3-9, 2013. ,
Defining the clinical course of multiple sclerosis: results of an international survey. National Multiple Sclerosis Society (USA) Advisory Committee on Clinical Trials of New Agents in Multiple Sclerosis, Neurology, vol.46, pp.907-911, 1996. ,
Defining the clinical course of multiple sclerosis: the 2013 revisions, Neurology, vol.83, pp.278-286, 2014. ,
Incidental MRI anomalies suggestive of multiple sclerosis: the radiologically isolated syndrome, Neurology, vol.72, pp.800-805, 2009. ,
Comparison of MRI criteria at first presentation to predict conversion to clinically definite multiple sclerosis, Brain, vol.120, pp.2059-2069, 1997. ,
Cognitive function in radiologically isolated syndrome, Mult. Scler. J, vol.16, pp.919-925, 2010. ,
URL : https://hal.archives-ouvertes.fr/hal-00617782
Characteristics of Radiologically isolated syndrome (RIS) national ,
, , p.1, 2019.
, Clinically isolated syndromes. Lancet Neurol, vol.11, pp.157-169, 2012.
Disability and T2 MRI lesions: a 20-year follow-up of patients with relapse onset of multiple sclerosis, Brain, vol.131, pp.808-817, 2008. ,
Long-term follow up of patients with clinically isolated syndromes, relapsing-remitting and secondary progressive multiple sclerosis, Mult. Scler. J, vol.9, pp.260-274, 2003. ,
Update on clinically isolated syndrome ,
URL : https://hal.archives-ouvertes.fr/hal-01934891
Interaction between HLA-DR2 and abnormal brain MRI in optic neuritis and early MS, Am. J. Ophthalmol, vol.130, pp.690-691, 2000. ,
Oligoclonal bands and age at onset correlate with genetic risk score in multiple sclerosis, Mult. Scler. Houndmills Basingstoke Engl, vol.20, pp.660-668, 2014. ,
The 11-year long-term follow-up study from the randomized BENEFIT CIS trial, Neurology, vol.87, pp.978-987, 2016. ,
URL : https://hal.archives-ouvertes.fr/inserm-01576482
A comparative analysis of diagnosis delays when applying the, Salimata Gassama, 2017. ,
Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the diagnosis of multiple sclerosis, Ann. Neurol, vol.50, pp.121-127, 2001. ,
Differential diagnosis of suspected multiple sclerosis: a consensus approach, Mult. Scler. Houndmills Basingstoke Engl, vol.14, pp.1157-1174, 2008. ,
Critères diagnostiques de la sclérose en plaques ,
Diagnostic criteria for multiple sclerosis: 2010 Revisions to the McDonald criteria, Ann. Neurol, vol.69, pp.292-302, 2011. ,
Primary-progressive multiple sclerosis, Lancet Neurol, vol.6, pp.903-912, 2007. ,
URL : https://hal.archives-ouvertes.fr/hal-01880998
Evidence for a two-stage disability progression in multiple sclerosis, Brain, vol.133, pp.1900-1913, 2010. ,
Ocrelizumab versus Placebo in Primary Progressive Multiple Sclerosis, 2016. ,
URL : https://hal.archives-ouvertes.fr/hal-01793440
Pathological mechanisms in progressive multiple sclerosis, Lancet Neurol, vol.14, pp.183-193, 2015. ,
Occurrence of oligoclonal bands in multiple sclerosis and other CNS diseases, Ann. Neurol, vol.13, pp.53-58, 1983. ,
Class II HLA interactions modulate genetic risk for multiple sclerosis, Nat. Genet, vol.47, pp.1107-1113, 2015. ,
, Experimental in vivo and in vitro models of multiple sclerosis: EAE and beyond
, , p.10, 2019.
Immunopathology of multiple sclerosis: report on an international meeting held at the Institute of Neurology of the University of Vienna, J. Neuroimmunol, vol.86, pp.213-217, 1998. ,
An updated histological classification system for multiple sclerosis lesions, Acta Neuropathol. (Berl.), vol.133, pp.13-24, 2017. ,
Encephalitogenic potential of the myelin basic protein peptide (amino acids 83-99) in multiple sclerosis: results of a phase II clinical trial with an altered peptide ligand, Nat. Med, vol.6, pp.1167-1175, 2000. ,
A humanized model for multiple sclerosis using HLA-DR2 and a human T-cell receptor, Nat. Genet, vol.23, pp.343-347, 1999. ,
, Ome Sweet 'Omics -A Genealogical Treasury of Words
, Medicine, p.15, 2019.
The role of gut microbiota in shaping the relapse-remitting and chronic-progressive forms of multiple sclerosis in mouse models, Sci. Rep, vol.9, p.6923, 2019. ,
AN ELECTROPHORETIC STUDY OF THE PROTEIN COMPONENTS IN CEREBROSPINAL FLUID AND THEIR RELATIONSHIP TO THE SERUM PROTEINS, J. Clin. Invest, vol.21, pp.571-577, 1942. ,
B-cell Therapy for Multiple Sclerosis: Entering an era ,
, Ann. Neurol, vol.83, pp.13-26, 2018.
B-Cell Depletion with Rituximab in Relapsing-Remitting Multiple Sclerosis, N. Engl. J. Med, vol.358, pp.676-688, 2008. ,
,
, Update on the autoimmune pathology of multiple sclerosis: B cells as disease-drivers and therapeutic targets, Eur. Neurol, vol.73, pp.238-246, 2015.
Targeting IL-17 and TH17 cells in chronic inflammation, Nat. Rev. Drug Discov, vol.11, pp.763-776, 2012. ,
A single dose of rituximab does not deplete B cells in secondary lymphoid organs but alters phenotype and function, Am. J. Transplant. Off. J. Am. Soc. Transplant. Am. Soc. Transpl. Surg, vol.13, pp.1503-1511, 2013. ,
Blood-brain barrier disruption in multiple sclerosis ,
, Houndmills Basingstoke Engl, vol.9, pp.540-549, 2003.
Tumor necrosis factor-alpha induces neurotoxicity via glutamate release from hemichannels of activated microglia in an autocrine manner, J. Biol. Chem, vol.281, pp.21362-21368, 2006. ,
Differential roles of microglia and monocytes in the inflamed central nervous system, J. Exp. Med, vol.211, pp.1533-1549, 2014. ,
Twin concordance and sibling recurrence rates in multiple sclerosis ,
, Proc. Natl. Acad. Sci. U. S. A, vol.100, pp.12877-12882, 2003.
Concordance for multiple sclerosis in Danish twins: an update of a nationwide study, Mult. Scler. Houndmills Basingstoke Engl, vol.11, pp.504-510, 2005. ,
Genome, epigenome and RNA sequences of monozygotic twins discordant for multiple sclerosis, Nature, vol.464, pp.1351-1356, 2010. ,
Age-adjusted recurrence risks for relatives of patients with multiple sclerosis, Brain J. Neurol, vol.119, issue.2, pp.449-455, 1996. ,
The Genetics of Multiple Sclerosis: From 0 to ,
, Trends Genet. TIG, vol.33, pp.960-970, 2017.
Time matters in multiple sclerosis: can early treatment and long-term follow-up ensure everyone benefits from the latest advances in multiple sclerosis?, J. Neurol. Neurosurg. Psychiatry, vol.89, pp.844-850, 2018. ,
Long-term safety and effectiveness of natalizumab redosing and treatment in the STRATA MS Study, Neurology, vol.83, pp.78-86, 2014. ,
Identification and development of new therapeutics for multiple sclerosis, Trends Pharmacol. Sci, vol.29, pp.558-565, 2008. ,
Ocrelizumab versus Placebo in Primary Progressive Multiple Sclerosis, N. Engl. J. Med, vol.376, pp.209-220, 2017. ,
URL : https://hal.archives-ouvertes.fr/hal-01793440
Siponimod versus placebo in secondary progressive multiple sclerosis (EXPAND): a double-blind, randomised, phase 3 study, The Lancet, vol.391, pp.1263-1273, 2018. ,
Clinical outcome measures for research in multiple sclerosis ,
, Off. J. North Am. Neuro-Ophthalmol. Soc, vol.21, pp.296-301, 2001.
Studies on the natural history of multiple sclerosis. 1. Design and diagnosis, Acta Neurol. Scand, vol.42, pp.141-156, 1966. ,
On the evaluation of disability in multiple sclerosis, Neurology, vol.11, pp.686-694, 1961. ,
Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS), Neurology, vol.33, pp.1444-1452, 1983. ,
Multiple sclerosis in men: management considerations, J. Neurol, vol.263, pp.1263-1273, 2016. ,
Evaluating upper limb impairments in multiple sclerosis by exposure to different mechanical environments, Sci. Rep, vol.8, 2018. ,
Control and training of individual motor units, Science, vol.141, pp.440-441, 1963. ,
Clinical utility of surface EMG: report of the therapeutics and technology assessment subcommittee of the American Academy of Neurology, Neurology, vol.55, pp.171-177, 2000. ,
Big Data For Dummies, 2013. ,
Bigdata, artificial intelligence and blockchain for dummies, Rev. Med. Suisse, vol.14, pp.1559-1563, 2018. ,
Finger tapping impairments are highly sensitive for evaluating upper motor neuron lesions, BMC Neurol, vol.17, 2017. ,
The Nine-Hole Peg Test as a manual dexterity performance measure for multiple sclerosis, Mult. Scler. Houndmills Basingstoke Engl, vol.23, pp.711-720, 2017. ,
A questionnaire to assess neurological impairment in multiple sclerosis ,
, Mult. Scler. Houndmills Basingstoke Engl, vol.4, pp.444-451, 1998.
, Current state of digital signal processing in myoelectric interfaces and related applications | Elsevier Enhanced Reader
Gait variability in people with multiple sclerosis, Mult. Scler. Houndmills Basingstoke Engl, vol.12, pp.613-619, 2006. ,
Analysis of foot and ankle disorders and prediction of gait in multiple sclerosis rehabilitation, Eur. J. Med. Res, vol.19, p.73, 2014. ,
Gait abnormalities in minimally impaired multiple sclerosis patients, Mult. Scler. Houndmills Basingstoke Engl, vol.5, pp.363-368, 1999. ,
Strength, skeletal muscle composition, and enzyme activity in multiple sclerosis, J. Appl. Physiol. Bethesda Md, vol.83, 1985. ,
Functional relationships of central and peripheral muscle alterations in multiple sclerosis, Muscle Nerve, vol.29, pp.843-852, 2004. ,
Gait and balance impairment in early multiple sclerosis in the absence of clinical disability, Mult. Scler. Houndmills Basingstoke Engl, vol.12, pp.620-628, 2006. ,
,
, Brain Res, vol.175, pp.453-464, 2009.
Dynamics of oligodendrocyte generation in multiple sclerosis, Nature, vol.566, pp.538-542, 2019. ,
URL : https://hal.archives-ouvertes.fr/hal-02002274
Cortical functional reorganization and its relationship with brain structural damage in patients with benign multiple sclerosis, Mult. Scler. J, vol.16, pp.1326-1334, 2010. ,
Cortical adaptation in patients with MS: a cross-sectional functional MRI study of disease phenotypes, Lancet Neurol, vol.4, pp.618-626, 2005. ,
Supraspinal control of automatic postural responses in people with multiple sclerosis, Gait Posture, vol.47, pp.92-95, 2016. ,
How changes in brain activity and connectivity are associated with motor performance in people with MS, NeuroImage Clin, vol.17, pp.153-162, 2018. ,